CIK 0001006281 · Non-accelerated filer<br>Smaller reporting company
Protalix BioTherapeutics, Inc.
Sign in to watch- Ticker
- PLX
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 650643773
- Phone
- 201-696-9345
- Business address
- 2 UNIVERSITY PLAZA, SUITE 100, HACKENSACK, NJ, 07601
- Former names
- ORTHODONTIX INC, EMBASSY ACQUISITION CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 82 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2013-03-11 | Akirov Alfred Director | Sale | −3,000 | $5.75 | $17K | 5,052,713 |
| 2013-03-11 | Akirov Alfred Director | Sale | −10,000 | $5.72 | $57K | 5,042,713 |
| 2013-03-11 | Akirov Alfred Director | Sale | −5,000 | $5.71 | $29K | 5,037,711 |
| 2013-03-08 | Akirov Alfred Director | Sale | −10,000 | $5.82 | $58K | 5,062,911 |
| 2013-03-08 | Akirov Alfred Director | Sale | −2,500 | $5.91 | $15K | 5,060,411 |
| 2013-03-08 | Akirov Alfred Director | Sale | −2,500 | $5.92 | $15K | 5,057,911 |
| 2013-03-08 | Akirov Alfred Director | Sale | −1,898 | $5.95 | $11K | 5,056,013 |
| 2013-03-07 | Akirov Alfred Director | Sale | −5,000 | $5.71 | $29K | 5,076,346 |
| 2013-03-07 | Akirov Alfred Director | Sale | −3,435 | $5.73 | $20K | 5,072,911 |
| 2013-03-06 | Akirov Alfred Director | Sale | −2,000 | $5.68 | $11K | 5,084,046 |
| 2013-03-06 | Akirov Alfred Director | Sale | −2,000 | $5.69 | $11K | 5,082,046 |
| 2013-03-06 | Akirov Alfred Director | Sale | −700 | $5.71 | $4K | 5,081,346 |
| 2012-07-16 | Lauterbach Sandra Leigh VP, Sales & Commercial Affairs | Grant or award | +20,000 | 20,000 | ||
| 2012-07-16 | Palash Tzvi Chief Operating Officer | Grant or award | +102,000 | 102,000 | ||
| 2012-07-16 | Maimon Yossi Vice President & CFO | Grant or award | +185,000 | 185,000 | ||
| 2012-07-16 | Almon Einat Brill SVP, Product Development | Grant or award | +185,000 | 185,000 | ||
| 2012-07-16 | Shaaltiel Yoseph Executive VP, R&D | Grant or award | +210,000 | 210,000 | ||
| 2012-07-16 | Aviezer David President & CEO | Grant or award | +418,000 | 418,000 | ||
| 2012-05-02 | Shaaltiel Yoseph Executive VP, R&D | Sale | −300,000 | $7.13 | $2.1M | 463,754 |
Page 7 of 7 · 139 trades